AU2001270858A1 - Novel processes for the preparation of 4-phenylpiperidine derivatives - Google Patents

Novel processes for the preparation of 4-phenylpiperidine derivatives

Info

Publication number
AU2001270858A1
AU2001270858A1 AU2001270858A AU7085801A AU2001270858A1 AU 2001270858 A1 AU2001270858 A1 AU 2001270858A1 AU 2001270858 A AU2001270858 A AU 2001270858A AU 7085801 A AU7085801 A AU 7085801A AU 2001270858 A1 AU2001270858 A1 AU 2001270858A1
Authority
AU
Australia
Prior art keywords
preparation
novel processes
phenylpiperidine derivatives
phenylpiperidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270858A
Other languages
English (en)
Inventor
Gary Thomas Borrett
Michael Fedouloff
Mark Jason Hughes
Andrew Colin Share
John Bryce Strachan
Peter Szeto
Martyn Voyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0017540A external-priority patent/GB0017540D0/en
Priority claimed from GB0018857A external-priority patent/GB0018857D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001270858A1 publication Critical patent/AU2001270858A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2001270858A 2000-07-17 2001-07-17 Novel processes for the preparation of 4-phenylpiperidine derivatives Abandoned AU2001270858A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0017540A GB0017540D0 (en) 2000-07-17 2000-07-17 Novel compounds
GB0017540 2000-07-17
GB0018857 2000-08-01
GB0018857A GB0018857D0 (en) 2000-08-01 2000-08-01 Novel process
PCT/GB2001/003221 WO2002006275A1 (en) 2000-07-17 2001-07-17 Novel processes for the preparation of 4-phenylpiperidine derivatives

Publications (1)

Publication Number Publication Date
AU2001270858A1 true AU2001270858A1 (en) 2002-01-30

Family

ID=26244675

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270858A Abandoned AU2001270858A1 (en) 2000-07-17 2001-07-17 Novel processes for the preparation of 4-phenylpiperidine derivatives

Country Status (5)

Country Link
US (1) US20040087795A1 (ja)
EP (1) EP1301508A1 (ja)
JP (1) JP2004504319A (ja)
AU (1) AU2001270858A1 (ja)
WO (1) WO2002006275A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777554B2 (en) * 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
US8946329B2 (en) 2003-08-25 2015-02-03 Dow Global Technologies Llc Coating compositions
US9169406B2 (en) 2003-08-25 2015-10-27 Dow Global Technologies Llc Coating compositions
TW200530236A (en) 2004-02-23 2005-09-16 Chugai Pharmaceutical Co Ltd Heteroaryl phenylurea
WO2006071868A2 (en) * 2004-12-23 2006-07-06 Teva Pharmaceutical Industries Ltd. Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US9422444B2 (en) 2012-12-28 2016-08-23 Dow Global Technologies Llc Coating compositions
JP6258968B2 (ja) 2012-12-28 2018-01-10 ダウ グローバル テクノロジーズ エルエルシー コーティング組成物およびそれから作製される物品
CA2928205C (en) * 2013-11-18 2020-04-21 Mallinckrodt Llc Preparation of normorphinans
CN104447714A (zh) * 2014-11-18 2015-03-25 成都医路康医学技术服务有限公司 一种盐酸帕罗西汀的生产工艺
CN112521377A (zh) * 2020-11-26 2021-03-19 北京福元医药股份有限公司 一种盐酸帕罗西汀的连续化制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
NZ307479A (en) * 1995-05-17 1999-08-30 Novo Nordisk As A process for preparing 4-(4-halo substituted phenyl)-3-(3,4-methylenedioxy phenoxy methyl)piperidine derivatives
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
GB9916187D0 (en) * 1999-07-09 1999-09-08 Smithkline Beecham Plc Novel process
US6777554B2 (en) * 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds

Also Published As

Publication number Publication date
JP2004504319A (ja) 2004-02-12
US20040087795A1 (en) 2004-05-06
WO2002006275A1 (en) 2002-01-24
EP1301508A1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2002332638A1 (en) Method for the preparation of crystalline tetrahydrobenzothiepines
AU2002241793A1 (en) Process for the preparation of organoclays
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU2001270858A1 (en) Novel processes for the preparation of 4-phenylpiperidine derivatives
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
AU2001262226A1 (en) Process for the preparation of sterically hindered aryloxyamines
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
AU2002214976A1 (en) Process for the preparation of benzotriazoles
AU2002310034A1 (en) Process for the preparation of 3-hydroxypropanal
AU3818900A (en) Process for the preparation of substituted piperidines
AU2943400A (en) Process for the preparation of alpha-aminoketone derivatives
AU1037901A (en) Process for the preparation of paroxetine
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU2002337601A1 (en) Process for the preparation of simvastatin
AU2002310898A1 (en) Process for the preparation of a polymer-amine
AU2001258718A1 (en) An improved process for the preparation of quinolone derivatives
AU2002358085A1 (en) Process for the preparation of 4-methyl-7-aminoquinolones
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU2002324291A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
AU2000279379A1 (en) An improved process for the preparation of 10h-phenoxazine
AU2000258438A1 (en) An improved process for the preparation of acylferrocenes
AU2001227095A1 (en) Processes for the preparation of carbapenem derivatives